Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents

Nuclear Medicine and Biology

Volumn 26, Issue 3, 1999, Pages 297-304

  Tsoukalas, C ^a   Papadopoulos, M S ^a   Maina, T ^a   Pirmettis, I C ^a   Nock, B A ^a   Raptopoulou, C ^a   Terzis, A ^a   Chiotellis, E ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Brain perfusion; Brain retention; Pendant ester hydrolysis; Rhenium; SNS S mixed ligand complexes; Technetium

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; ESTERASE; RADIOLIGAND; RHENIUM; TECHNETIUM;

ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DRUG SCREENING; DRUG SYNTHESIS; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MALE; MOUSE; NONHUMAN; RADIOISOTOPE DISTRIBUTION;

EID: 0033118438     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00093-6     Document Type: Article

References (27)

1. Afshan A., Jehangir M., Ashraf M., Waqar A., Chiotellis E. Formulation of a single-component kit for the preparation of technetium-99m labelled ethyl cysteinate dimer Biological and clinical evaluation . Eur. J. Nucl. Med. 21:1994;991-995.
2. Campaigne E., Meyer W.W. Preparation and absorption spectra of p-mercaptocinnamic and p-mercaptobenzoic acids and derivatives. J. Org. Chem. 27:1962;2835-2841.
3. Chatt J., Rowe G.A. Complex compounds of tertiary phosphines and a tertiary arsine of rhenium (V), rhenium (III) and rhenium (II). J. Chem. Soc. 1962;4019-4033.
4. 2+ core. Inorg. Chim. Acta. 90:1984;41-51.
5. 99mTc. Preliminary distribution studies in animals. Nicolini M., Bandoli B., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine. 1994;547-550 Servizi Grafici Editoriali, Padova, Italy.
6. Harley-Mason J. Some aliphatic thiols and their derivatives. Part I. Aliphatic mercaptans. J. Chem. Soc. 1947;320-322.
7. Jacquier-Sarlin M.R., Polla B.S., Slosman D.O. Cellular basis of ECD brain retention. J. Nucl. Med. 37:1996;1694-1697.
8. 99mTc-bicisate (ECD, Neurolite) measured by SPECT on the same day . J. Cereb. Blood Flow Metab. 14:(suppl.):1994;S44-S48.
9. Leveille J., Demonceau G., De Roo M., et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2 Biodistribution and brain imaging in humans . J. Nucl. Med. 30:1989;1902-1910.
10. Mann F. Hofman's ethylene bases. Synthesis of β,β′-diaminodiethylamine and β,β′-diaminodiethylmethylamine. J. Chem. Soc. 1934;461-466.
11. 3-donor ligands as a new backbone for reduced technetium. Eur. J. Nucl. Med. 16:1990;109.
12. Mastrostamatis S., Papadopoulos M., Pirmettis I.C., Paschali E., et al. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain imaging agents. J. Med. Chem. 37:1994;3212-3218.
13. Moretti J.L., Caglar M., Weinmann P. Cerebral perfusion imaging tracers for SPECT Which one to choose? J. Nucl. Med. 36:1995;359-363.
14. Papadopoulos M.S., Pirmettis I.C., Pelecanou M., Raptopoulou C.P., Terzis A., Stassinopoulou C.I., Chiotellis E. Syn-Anti isomerism in a mixed-ligand oxorhenium complex ReO[SN(R)S][S]. Inorg. Chem. 35:1996;7377-7383.
15. Papadopoulos M., Pirmettis I., Raptopoulou C., Chiotellis E., Friebe M., Berger R., Spies H., Johannsen B. Synthesis, structure, lipophilicity and protonation behaviour of mixed ligand rhenium chelates functionalized by amine groups. Appl. Radiat. Isot. 49:1998;961-966.
16. Papazyan J.P., Delavelle J., Burkhard P., Rossier P., et al. Discrepancies between HMPAO and ECD SPECT imaging in brain tumors. J. Nucl. Med. 38:1997;592-596.
17. 99mTc aminobis-thiolato/monothiolato "3 + 1" mixed ligand complexes Structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents . J. Med. Chem. 40:1997;2539-2546.
18. Pirmettis I.C., Papadopoulos M.S., Mastrostamatis C.P., Raptopoulou C.P., Terzis A., Chiotellis E. Synthesis and characterization of oxotechnetium(V) mixed-ligand complexes containing a tridentate N-substituted bis-(2-mercaptoethyl)amine and a monodentate thiol. Inorg. Chem. 35:1996;1685-1691.
19. Sheldrick G. M. (1986) SHELXS-86: Structure solving program. University of Goettingen, Germany.
20. Sheldrick G. M. (1993) SHELXL-93: Crystal structure refinement. University of Goettingen, Germany.
21. Spies H., Pietzch H.J., Syhre R., Hoffmann S. Lipophilic technetium complexes - VIII. Preparation and animal studies of oxotechnetium(V) complexes with tridentate/monodentate ligand coordination. Isotopenpraxis. 26:1990;159-162.
22. Spyriounis D.M., Pelecanou M., Stassinopoulou C.I., Raptopoulou C.P., Terzis A., Chiotellis E. Synthesis and characterization of oxotechnetium(V) complexes with aza-substituted 2,6-dimethyl-4-azaheptane-2,6-dithiol ligands and benzyl mercaptan as coligand. Inorg. Chem. 34:1995;1077-1082.
23. Tsuchida T., Nishizawa S., Yonekura Y., Sadato N., Iwasaki Y., Fujita T., Matoba N., Magata Y., Tamaki N., Konishi J. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases Comparison with other cerebral perfusion tracers and PET . J. Nucl. Med. 35:1994;27-31.
24. 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology. 30:1991;283-292.
25. Walovitch R.C., Hill T.C., Garrity S.T., Cheesman E.H., Burgess B.A., O'Leary D.H., Watson A.D., Ganey M.V., Morgan R.A., Williams S.J. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1 Pharmacology of technetium-99m ECD in nonhuman primates . J. Nucl. Med. 30:1989;1892-1901.
26. Walovitch R.C., Makuch J., Garrity S., et al. Neuropharmacological characterization of Tc99m ECD in human and non-human primates. Neurology. 38:1988;363.
27. Wineman R.J., Gollis M.H., James J.C., Pomponi A.M. Thioethylation of amines with ethylene sulfide. J. Org. Chem. 27:1962;4222-4226.